Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.705
+0.145 (4.07%)
At close: Aug 17, 2026, 4:00 PM EDT
3.770
+0.065 (1.75%)
After-hours: Aug 17, 2026, 7:55 PM EDT
Zentalis Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Zentalis Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $6.89. The average 1-year stock price forecast is 85.96% higher than the current stock price, while the lowest is $4.00 (+7.96%) and the highest is $10 (+169.91%).
Price Target: $6.89 (+85.96%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Zentalis Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Reiterates $8 | Buy | Reiterates | $8 | +115.92% | Aug 11, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $4 → $5 | Hold | Reiterates | $4 → $5 | +34.95% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $10 | Buy | Maintains | $10 | +169.91% | Aug 7, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $10 | Buy | Maintains | $10 | +169.91% | Aug 7, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $11 | Buy | Initiates | $11 | +196.90% | Jul 23, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
16.38M
EPS This Year
-2.11
from -1.80
EPS Next Year
-1.80
from -2.11
EPS and Forward PE are based on non-GAAP adjusted numbers.